MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 9 analysts with an average price target of $598.74. This is a potential upside of $104.05 (21.03%) from yesterday's end of day stock price of $494.69.

Madrigal Pharmaceuticals's activity chart (see below) currently has 214 price targets and 150 ratings on display. The stock rating distribution of MDGL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.94% with an average time for these price targets to be met of 434.67 days.

Highest price target for MDGL is $900, Lowest price target is $405, average price target is $599.22.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 20-Jan-2026. First documented stock forecast 29-Oct-2014.

Currently out of the existing stock ratings of MDGL, 19 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-May-2022

$745

$264.55 (55.06%)

$485

10 days ago
(20-Jan-2026)

14/15 (93.33%)

$240.05 (47.54%)

385

Buy Since 16-Mar-2018

$900

$419.55 (87.32%)

$540

1 months 11 days ago
(19-Dec-2025)

16/17 (94.12%)

$308.98 (52.28%)

345

Buy Since 01-Jun-2018

$650

$169.55 (35.29%)

$590

2 months 10 days ago
(20-Nov-2025)

12/14 (85.71%)

$107.88 (19.90%)

324

Buy Since 30-Jan-2020

$587

$106.55 (22.18%)

$526

2 months 17 days ago
(13-Nov-2025)

16/16 (100%)

$58.06 (10.98%)

335

Buy Since 02-May-2025

$560

$79.55 (16.56%)

$460

4 months 1 days ago
(29-Sep-2025)

12/14 (85.71%)

$116.9 (26.38%)

238

Show more analysts

Please expand the browser size to see the chart

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 434.67 days on average for the stock forecasts to be realized with a an average price target met ratio 94.94

Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?

ANDREA TAN

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Andrea Tan works at GOLDMAN SACHS and has 7 price targets and 4 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $419.55

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Matthew Luchini with lowest potential downside - -$369.45

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?